Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rachel J. Grimm"'
Autor:
Irina Kapitanova, Sharmi Biswas, Sabrina Divekar, Eric J. Kemmerer, Robert A. Rostock, Kenneth M. Forster, Rachel J. Grimm, Carla J. Scofield, Jimm Grimm, Bahman Emami, Anand Mahadevan
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-13 (2021)
Abstract Background Brachial plexopathy is a potentially serious complication from stereotactic body radiation therapy (SBRT) that has not been widely studied. Therefore, we compared datasets from two different institutions and generated a brachial p
Externí odkaz:
https://doaj.org/article/b873e39572634ac6aab52c7de1f01ff5
Autor:
Kenneth M. Forster, Anand Mahadevan, Sabrina Divekar, Sharmi Biswas, Robert A Rostock, Jimm Grimm, Irina Kapitanova, Carla J Scofield, Rachel J Grimm, Bahman Emami, Eric Kemmerer
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-13 (2021)
Radiation Oncology (London, England)
Radiation Oncology (London, England)
Background Brachial plexopathy is a potentially serious complication from stereotactic body radiation therapy (SBRT) that has not been widely studied. Therefore, we compared datasets from two different institutions and generated a brachial plexus dos
Autor:
Diane C, Ling, John A, Vargo, Rachel J, Grimm, Brian J, Gebhardt, David A, Clump, Robert L, Ferris, James P, Ohr, Dwight E, Heron
Publikováno v:
J Radiosurg SBRT
We sought to evaluate the association between larynx dose and risk of severe late laryngeal toxicity in patients undergoing re-irradiation SBRT for recurrent HNC. Fifty-five patients with an intact larynx underwent re-irradiation SBRT to a median dos
Autor:
Diane C, Ling, John A, Vargo, Brian J, Gebhardt, Rachel J, Grimm, David A, Clump, Robert L, Ferris, James P, Ohr, Dwight E, Heron
Publikováno v:
Journal of radiosurgery and SBRT. 6(2)
Given the lack of clear dose constraints for the carotid artery, we created dose-response models to better quantify the risk of carotid bleeding events following re-irradiation stereotactic body radiation therapy (SBRT) for head and neck cancer (HNC)
Autor:
Dwight E. Heron, James Ohr, Rachel J Grimm, Diane C. Ling, David A. Clump, Brian J. Gebhardt, Robert L. Ferris, John A. Vargo
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:E6
We sought to evaluate the association between larynx dose and risk of severe late laryngeal toxicity in patients undergoing re-irradiation SBRT for recurrent HNC. Fifty-five patients with an intact larynx underwent re-irradiation SBRT to a median dos
Autor:
Ellen Huang, Juan Jackson, Rachel J Grimm, Joseph Moore, Lawrence Kleinberg, Kristin J. Redmond, T. Hooker, Jimm Grimm
Publikováno v:
Neuro-Oncology. 19:vi223-vi223
Tumor treating fields (TTFields) is a noninvasive, regional antimitotic treatment approved for the treatment of newly-diagnosed and recurrent glioblastoma (GBM) including use concurrent with temozolomide. As anti-mitotic therapies may have synergy wi